&nbsp;

Nov 2022

Drug

crizotinib

Other Name(s): Xalkori®

Quick Link(s):

Jan 2022

Drug

PERTuzumab

Other Name(s): Perjeta®

Quick Link(s):

Sep 2022

Drug

oBINutuzumab

Other Name(s): Gazyva®

Quick Link(s):

May 2022

Drug

idelalisib

Other Name(s): Zydelig™

Quick Link(s):

Feb 2022

Regimen

CYCLDOCE; CYCLDOCE+TRAS

Cancer Type:

Breast

Intent: Adjuvant

Funding:

New Drug Funding Program

Trastuzumab (Biosimilar) - Adjuvant Treatment for Breast Cancer

Drugs Used:

Quick Link(s):

Regimen Monograph, Patient Info Sheet (CYCLDOCE)

Jan 2024

Regimen

LENA

Cancer Type:

Hematologic,

Myelodysplastic Syndrome (MDS)

Intent: Palliative

Funding:

ODB Limited Use

lenalidomide - For the treatment of patients with anemia due to myelodysplastic syndrome (MDS), according to clinical criteria

Drugs Used:

lenalidomide

Quick Link(s):

Regimen Monograph

May 2022

Regimen

MVAC(HD)

Cancer Type:

Genitourinary,

Bladder / Urothelial

Intent: Neoadjuvant, Adjuvant, Palliative

Drugs Used:

Quick Link(s):

Regimen Monograph

Sep 2022

Regimen

CISPGEMC

Cancer Type:

Head and Neck

Intent: Palliative

Drugs Used:

gemcitabine,

CISplatin

Quick Link(s):

Regimen Monograph, Patient Info Sheet

Jan 2024

Regimen

PMDR

Cancer Type:

Breast

Intent: Palliative

Drugs Used:

pamidronate

Quick Link(s):

Regimen Monograph

Jan 2024

Regimen

TMXF

Cancer Type:

Breast

Intent: Palliative

Funding:

ODB - General Benefit

tamoxifen

Drugs Used:

tamoxifen

Quick Link(s):

Regimen Monograph

May 2022

Regimen

CRBPGEMC

Cancer Type:

Genitourinary,

Bladder / Urothelial

Intent: Neoadjuvant, Adjuvant, Palliative

Drugs Used:

gemcitabine,

CARBOplatin